A provocative new study in the current issue of Circulation Research by Ibarra et al 1 suggests that insulin-like growth factor 1 receptors (IGF-1R) exist in plasma membrane invaginations that come in very close proximity to (or even invade) the nuclear membrane in cardiac myocytes to selectively raise local nuclear [Ca 2+ ]. This article raises an intriguing and novel mechanism by which plasma membrane receptors may have preferential local access to nuclear signaling, even in ventricular myocytes which are large cells with central nuclei.
Editorial
A provocative new study in the current issue of Circulation Research by Ibarra et al 1 suggests that insulin-like growth factor 1 receptors (IGF-1R) exist in plasma membrane invaginations that come in very close proximity to (or even invade) the nuclear membrane in cardiac myocytes to selectively raise local nuclear [Ca 2+ ]. This article raises an intriguing and novel mechanism by which plasma membrane receptors may have preferential local access to nuclear signaling, even in ventricular myocytes which are large cells with central nuclei.
Article, see p 236
The IGF-1R is a tyrosine kinase growth factor receptor that connects with many downstream signaling cascades. 2 The 2 best-known pathways are Ras-Raf-mitogen-activated protein kinase and phosphatidylinositide 3 kinase-protein kinase B (Akt). However, Ibarra et al 1 focus on a less well-studied pathway in which IGF-1 induces G i -dependent phospholipase C activation 3 and 1,4,5-inositol trisphosphate (InsP 3 ) that can release Ca 2+ from intracellular InsP 3 receptor (InsP 3 R) stores. 4 They show that in cardiac myocytes IGF-1 triggers nuclear Ca 2+ transients that precede cytosolic Ca 2+ transients, and that blocking the nuclear Ca 2+ transient prevents the cytosolic Ca 2+ transient, but not vice versa. Their data are consistent with the idea that a substantial fraction of plasma membrane IGF-R1 are in patches of plasma membrane invaginations that are extremely close to the nucleus, potentially as extensions of the transverse tubule (T-tubule) system. Further, they infer that these IGF-1R are G i -coupled and that upon activation they produce phospholipase C and InsP 3 -dependent nuclear Ca 2+ transients that contributes to Ca-dependent regulation of gene transcription (Figure, B) .
Although many plasma membrane receptors signal to the nucleus, there are numerous potential pathways for this signaling. Even if we constrain ourselves to a narrow field involving InsP 3 -dependent nuclear Ca 2+ signaling, 5 which has been extensively studied for G q -coupled receptors (eg, endothelin-1, α-adrenergic, and angiotensin II receptors), there may be 3 different organizations to consider ( Figure) . In what might now be considered the classical or traditional model (Figure, A), we showed that endothelin-1 triggered a rise in cytosolic [InsP 3 ] in adult ventricular myocytes that precedes the rise of [InsP 3 ] in the nucleus (using a fluorescence resonance energy transfer-based InsP 3 sensor), 6 and that most of the InsP 3 R in these myocytes is the type 2 InsP 3 R that is largely localized to the nuclear envelope and complexed with Ca-calmodulindependent protein kinase II (CaMKII). 7 We showed evidence for the hypothesis ( Figure A ) that endothelin-1 activation produces InsP 3 at the membrane which diffuses to nuclear InsP 3 R, elevating local [Ca 2+ ] there to effectively activate CaMKII (and protein kinase D)-dependent phosphorylation of histone deacetylase 5 to trigger histone deacetylase 5 nuclear export and de-repression of myocyte enhancer factor-2-dependent hypertrophic signaling. 5 It was known already that InsP 3 is better than Ca 2+ at long-distance signaling in cells 8 and that CaMKII and protein kinase D are histone deacetylase kinases which could drive histone deacetylase nuclear export and thus activate myocyte enhancer factor-2-dependent transcription. 9 Moreover, the high local [Ca] at the mouth of the InsP 3 R channel would facilitate CaMKII activation (which requires high local [Ca 2+ ]) in the nuclear environment. This working model nicely connects G q -coupled receptor activation to an important role for InsP 3 /Ca 2+ signaling in cardiac myocytes aside from excitation-contraction coupling, and connects nuclear InsP 3 R and CaMKII to transcriptional regulation in the heart downstream of G q -coupled receptor activation. Indeed, this allows Ca-dependent local signaling (around the InsP 3 R) to work in parallel to but independent of the global Ca 2+ transients associated with regular excitation-contraction coupling. 5 Ibarra et al 1 suggest an important extension to this concept (Figure, B) . They show evidence that an entire complex of receptor (in this case IGF-1R), G-protein, phospholipase C, and InsP 3 production is situated at the nucleus due to plasma membrane infoldings in direct apposition to the nuclear envelope. This would have the tremendous advantage of producing the InsP 3 very close to the InsP 3 R at the nucleus. It would greatly reduce the amount of InsP 3 production required to activate the local nuclear Ca transients. It also explains their observations of a faster rise in IGF-1-induced Ca transients in the nucleus versus cytosol that was most apparent in cultured neonatal rat ventricular myocytes. Their nuclear versus cytosolic difference in kinetics was not as clear in adult ventricular myocytes. However, Ca 2+ transients induced by IGF-1 were larger in the nucleus than cytosol, and that was opposite to what was seen with normal excitationcontraction coupling Ca 2+ transients. Thus, IGF-1 and InsP 3driven transients initiate first and strongest in the nucleus, whereas the normal beat-to-beat Ca 2+ transients initiate and are stronger in the cytosol. That is consistent with data suggesting that InsP 3 R activation promotes relatively stronger nuclear Ca 2+ signals, [10] [11] [12] although Ca 2+ indicator calibrations in nucleus may differ from that in the cytosol. 13 While it would be worthwhile to further test the model proposed by Ibarra, especially in adult ventricular myocytes, this is an intriguing structural organization.
There is also convincing evidence of a third organization of G-protein coupled receptor to InsP 3 /Ca 2+ signaling in the nucleus (Figure, C) . That is, some fraction of G q -coupled receptors seem to be functional, intracellular, and localized at or near the nucleus. [14] [15] [16] [17] [18] Indeed, there is evidence that many of the key molecules (G proteins, phospholipase C, and InsP 3 metabolizing proteins) are also at the nuclear membrane. Because the sarcoplasmic reticulum/endoplasmic reticulum network throughout ventricular myocytes is continuous with the nuclear envelope membranes, 19 the receptors and key signaling molecules could translocate to the nuclear envelope from endoplasmic reticulum without necessarily leaving that membrane. One issue for this organization is how the ligand (eg, norepinephrine or angiotensin II) gets across the plasma membrane to gain access to the internal receptor. In some cases that might be mediated by membrane transporters (eg, norepinephrine via extraneuronal monoamine transporter/organic cation transporter 3), 14 whereas in other it might represent an intracellular autocrine signaling pathway (eg, in response to myocyte produced angiotensin II). 15 It is quite plausible that all 3 of these receptor complex organizations coexist in cardiac myocytes, and maybe even for the same type of receptors. There are certainly details about each of these working models that need to be better worked out and validated. However, these models also raise intriguing questions regarding which pathway might be most important for (1) a given receptor type, (2) different types of signaling contexts, (3) cross-talk with different signaling networks, and (4) different pathophysiological conditions or pharmacological responses. So, as in real estate, location again matters and receptor complexes may take up residence in different neighborhoods for reasons that we have yet to figure out.
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